sulfinpyrazone has been researched along with probenecid in 124 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 89 (71.77) | 18.7374 |
1990's | 8 (6.45) | 18.2507 |
2000's | 18 (14.52) | 29.6817 |
2010's | 9 (7.26) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Strassburg, CP; Tukey, RH | 1 |
Topliss, JG; Yoshida, F | 1 |
Beijnen, JH; Borst, P; Reid, G; Saeki, T; Zelcer, N | 1 |
Chen, ZS; Kruh, GD; Kuwano, M; Lee, K; Raftogianis, RB; Walther, S; Zeng, H | 1 |
Honda, Y; Koyabu, N; Kuwano, M; Morimoto, S; Ohtani, H; Sawada, Y; Shoyama, Y; Uchiumi, T; Ushigome, F | 1 |
Chang, TK; Ensom, MH; Kiang, TK | 1 |
Cheng, CH; Fong, WP; Yu, Z | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Buda, E; Pollard, HB; Shulman, NR; Tack-Goldman, K | 1 |
Gancitano, A; Pallalardo, A | 1 |
Fanelli, GM | 1 |
Kleinschmidt, A; Schräpler, P; Schulz, E | 1 |
Emmerson, BT | 1 |
Simkin, PA | 1 |
Bayliss, RI | 1 |
McCarty, DJ | 2 |
Gordon, GV; Schumacher, HR | 1 |
Diamond, HS; Meisel, AD | 1 |
Alvsaker, JO | 1 |
Lowenthal, DT | 1 |
Yu, TF | 2 |
Kelley, WN | 2 |
Hunder, GG; Kelly, PJ; O'Duffy, JD | 1 |
Naess, K | 1 |
Iimura, O; Nakata, T | 1 |
Callahan, GN; Dinchuk, JE; Kelley, KA | 1 |
Gale, GR; Jones, MM; Singh, PK; Smith, AB; Tasende, MS | 1 |
Di Virgilio, F; Silverstein, SC; Steinberg, TH | 1 |
Brasch, H; Iven, H | 1 |
Schlapbach, P | 1 |
Lo, B | 1 |
Dayton, PG; Perel, JM | 1 |
Kippen, I; Klinenberg, JR; Whitehouse, MW | 1 |
Elion, GB | 1 |
Zöllner, N | 1 |
Gutman, AB | 3 |
Sans Solá, L | 1 |
Graul, EH; Müller, H | 1 |
Krebs, A; Zürcher, K | 1 |
Yü, T; Yu, TF | 1 |
Diamond, HS; Paolino, JS | 1 |
Fanelli, GM; Weiner, IM | 1 |
Bluestone, R; Campion, D; Klinenberg, JR; Whitehouse, M | 1 |
Diamond, HS; Sharon, E | 1 |
Gutman, AB; Yü, TF | 1 |
Mayr, E | 1 |
Goldfinger, SE | 1 |
Gottesbüren, H; Strohmeyer, G | 1 |
Kelley, WN; Wyngaarden, JB | 1 |
Healey, LA; Skeith, MD | 1 |
Bohn, DL; Fanelli, GM; Reilly, SS | 2 |
Ina, K; Ito, M; Suzuki, Y; Yamagami, I | 1 |
Boudry, JF | 1 |
Klotz, H; Prohaska, E; Salmhofer, H; Schmid, L | 1 |
Scott, JT | 1 |
Bluestone, R; Kippen, I; Klinenberg, JR | 1 |
Boudry, JF; Roch-Ramel, F | 1 |
Motawakel, AG | 1 |
Bluestone, R; Kippen, I; Klinenberg, JR; Whitehouse, M | 1 |
Bluestone, R; Kippen, I; Klinenberg, JR; Whitehouse, MW | 1 |
Munthe, E | 1 |
Riccitelli, ML | 1 |
Highton, TC; Palmer, DG | 1 |
Holländer, E; Schwarczmann, P | 1 |
Seegmiller, JE | 1 |
Bartels, EC | 1 |
Beck, IT; Dossetor, JB; Oh, JH | 1 |
Gaines, LM | 1 |
Champion, GD; Day, RO; Graham, GG; Lee, E | 1 |
Rodnan, GP | 1 |
Lyness, WH; Morin, RA | 1 |
Lyness, WH; Ramanadham, S | 1 |
Baiatova, KV | 1 |
Obel, AO | 1 |
Gut, JP | 1 |
Conaghan, PG; Day, RO | 1 |
Cao, C; Cohen, D; Hickman, S; Horwitz, SB; Neu, HC; Silverstein, SC; Steinberg, TH | 1 |
Burnside, B; García, DM | 1 |
Diezi, J; Guisan, B; Roch-Ramel, F | 1 |
Bergmann, R; Center, MS; Couraud, PO; El Hafny, B; Koman, A; Piciotti, M; Regina, A; Roux, F | 1 |
Beijnen, J; Borst, P; de Haas, M; Evers, R; Lankelma, J; Sparidans, R; Wielinga, PR | 1 |
DENKO, CW | 1 |
DUNCAN, H | 1 |
CARCASSONNE, Y | 1 |
MARSON, FG | 1 |
RIVERA, JV | 1 |
TREADWELL, B | 1 |
REAH, TG | 1 |
BLAU, RA; GIBBS, JO; GLOVER, RP; KUZELL, WC | 1 |
BLANCHARD, KC; MUDGE, GH; WEINER, IM | 1 |
LIPSON, RL; SLOCUMB, CH | 1 |
KUNIN, CM | 1 |
GOLDFINGER, S; KLINENBERG, JR; SEEGMILLER, JE | 1 |
RINGOIR, S | 1 |
SMYTH, CJ; VELAYOS, EE | 1 |
HILLECKE, NA | 1 |
LAVIETES, PH | 1 |
Beyer, TD; Dumitriu, IE; Gaipl, US; Herrmann, M; Kalden, JR; Roedel, F | 1 |
Crowe, A; Wong, P | 1 |
Russel, FG; Smeets, PH; van Aubel, RA; van den Heuvel, JJ; Wouterse, AC | 1 |
Caci, E; Diena, T; Galietta, LJ; Melani, R; Pedemonte, N; Sondo, E; Zegarra-Moran, O | 1 |
Basco, LK; Tahar, R | 1 |
Avorn, J; Brookhart, MA; Levin, R; Solomon, DH | 1 |
Andrade, SE; Briesacher, BA; Fouayzi, H; Harrold, LR; Ockene, IS; Raebel, MA; Yood, RA | 1 |
Anzai, N; Endou, H; Enomoto, A; Fujimura, M; Miyazaki, H; Shin, HJ; Takeda, M | 1 |
McClenaghan, C; Verkuyl, JM; Zeng, F | 1 |
Ingham, AB; Kotze, AC; Ruffell, AP | 1 |
Aviña-Zubieta, JA; Choi, HK; De Vera, MA; McCormick, N; Rai, SK; Sayre, EC; Shojania, K | 1 |
Bennuru, S; Flynn, AF; Joyce, MG; Lindrose, AR; Mitre, E; Morris, CP; Nutman, TB; Sterling, SL; Taylor, RT | 1 |
20 review(s) available for sulfinpyrazone and probenecid
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
Urate excretion.
Topics: Acetohexamide; Animals; Benzbromarone; Benzofurans; Diuretics; Ethambutol; Halofenate; Humans; Mersalyl; Pan troglodytes; Probenecid; Salicylates; Sulfinpyrazone; Uric Acid; Zoxazolamine | 1977 |
[Gout. Diagnosis--pathogenesis--therapy].
Topics: Allopurinol; Balneology; Benzofurans; Crystallization; Diagnosis, Differential; Exercise Therapy; Glomerular Filtration Rate; Gout; Probenecid; Sulfinpyrazone; Uric Acid; Urinary Calculi | 1978 |
Drug control of gout and hyperuricaemia.
Topics: Allopurinol; Arthritis; Chronic Disease; Colchicine; Gout; Humans; Indomethacin; Naproxen; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1978 |
Pharmacologic approach to the maintenance of urate homeostasis.
Topics: Allopurinol; Diuresis; Gout; Homeostasis; Humans; Kidney Tubules; Probenecid; Sulfinpyrazone; Uric Acid; Uricosuric Agents; Xanthine Oxidase | 1975 |
[Gout: diagnosis and therapy].
Topics: Allopurinol; Colchicine; Gout; Gout Suppressants; Humans; Indomethacin; Probenecid; Sulfinpyrazone | 1985 |
Physiological and physicochemical bases of drug interactions in man.
Topics: Animals; Carbon Isotopes; Chemical Phenomena; Chemistry; Chemistry, Physical; Chromatography, Thin Layer; Deuterium; Dextrans; Dicumarol; Dogs; Drug Antagonism; Drug Synergism; Humans; Kinetics; Male; Metabolism; Pharmaceutical Preparations; Phenylbutazone; Phenytoin; Probenecid; Protein Binding; Receptors, Drug; Salicylates; Stereoisomerism; Sulfinpyrazone; Sulfoxides; Thiopental | 1971 |
Pharmacology of uricosuric drugs.
Topics: Absorption; Animals; Anura; Biological Transport; Blood Proteins; Chemical Phenomena; Chemistry; Glomerular Filtration Rate; Haplorhini; Humans; Kidney Tubules; Pan troglodytes; Phenylbutazone; Probenecid; Protein Binding; Rats; Receptors, Drug; Salicylates; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1974 |
Crystal deposition joint disease.
Topics: Aged; Arthritis, Rheumatoid; Chondrocalcinosis; Colchicine; Crystallization; Diphosphates; Female; Gout; Humans; Indomethacin; Joint Diseases; Male; Phenylbutazone; Probenecid; Sulfinpyrazone; Synovial Fluid; Uric Acid; X-Ray Diffraction | 1974 |
Milestones in the treatment of gout.
Topics: Allopurinol; Colchicine; Gout; Humans; Indomethacin; Kidney Calculi; Probenecid; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1974 |
Principles of current management of primary gout.
Topics: Adult; Allopurinol; Diet Therapy; Female; Gout; Humans; Male; Middle Aged; Probenecid; Sulfinpyrazone | 1967 |
[Antarthritics. 41].
Topics: Acute Disease; Allopurinol; Antineoplastic Agents; Benzofurans; Colchicine; Female; Gout; Humans; Phenylbutazone; Pregnancy; Probenecid; Sulfinpyrazone; Uricosuric Agents; Vasodilator Agents; Zoxazolamine | 1969 |
Treatment of gout.
Topics: Adrenal Cortex Hormones; Allopurinol; Colchicine; Gout; Humans; Indomethacin; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid; Uricosuric Agents; Xanthine Oxidase; Xanthines | 1971 |
[What is certain in gout therapy?].
Topics: Acute Disease; Allopurinol; Chronic Disease; Colchicine; Gout; Humans; Hydrogen-Ion Concentration; Kidney Calculi; Kidney Tubules; Probenecid; Purines; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1971 |
Drug treatment of gout.
Topics: Acute Disease; Allopurinol; Arthritis; Colchicine; Gout; Humans; Orotic Acid; Probenecid; Structure-Activity Relationship; Sulfinpyrazone; Uric Acid; Uricosuric Agents; Xanthine Oxidase | 1971 |
Uricosuric drugs, with special reference to probenecid and sulfinpyrazone.
Topics: Gout; Humans; Male; Probenecid; Sulfinpyrazone; Uricosuric Agents | 1966 |
Anti-rheumatic drug interactions.
Topics: Adrenergic beta-Antagonists; Allopurinol; Animals; Antacids; Anti-Inflammatory Agents; Anticoagulants; Cimetidine; Diuretics; Drug Combinations; Drug Interactions; Glucocorticoids; Gold; Humans; Hypoglycemic Agents; Penicillamine; Probenecid; Sulfinpyrazone; Vasodilator Agents | 1984 |
Treatment of the gout and other forms of crystal-induced arthritis.
Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Benzbromarone; Colchicine; Gout; Gout Suppressants; Humans; Indomethacin; Kidney; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid | 1982 |
Risks and benefits of drugs used in the management and prevention of gout.
Topics: Adrenocorticotropic Hormone; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Double-Blind Method; Glucocorticoids; Gout; Gout Suppressants; Humans; Probenecid; Sulfinpyrazone | 1994 |
3 trial(s) available for sulfinpyrazone and probenecid
Article | Year |
---|---|
Comparison of allopurinol and probenecid.
Topics: Allopurinol; Clinical Trials as Topic; Colchicine; Enzyme Therapy; Follow-Up Studies; Gout; Humans; Liver Function Tests; Male; Probenecid; Sulfinpyrazone; Uric Acid; Xanthine Oxidase | 1966 |
Effect of drugs on urate binding to plasma proteins.
Topics: Adult; Allopurinol; Arthritis; Aspirin; Blood Proteins; Chromatography, DEAE-Cellulose; Colchicine; Female; Gout; Humans; Indomethacin; Male; Phenylbutazone; Probenecid; Protein Binding; Sulfinpyrazone; Uric Acid | 1969 |
Risks and benefits of drugs used in the management and prevention of gout.
Topics: Adrenocorticotropic Hormone; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Double-Blind Method; Glucocorticoids; Gout; Gout Suppressants; Humans; Probenecid; Sulfinpyrazone | 1994 |
102 other study(ies) available for sulfinpyrazone and probenecid
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3).
Topics: Animals; Biological Transport; Cell Line; Chromatography, High Pressure Liquid; Cloning, Molecular; DNA, Complementary; Drug Resistance, Multiple; Etoposide; Glutathione; Humans; Mice; Multidrug Resistance-Associated Proteins; Transfection | 2001 |
Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system.
Topics: Animals; Antimetabolites, Antineoplastic; Baculoviridae; Carrier Proteins; Cell Line; Folate Receptors, GPI-Anchored; Folic Acid; Insecta; Liposomes; LLC-PK1 Cells; Methotrexate; Multidrug Resistance-Associated Proteins; Osmosis; Polyglutamic Acid; Receptors, Cell Surface; Swine; Transfection | 2002 |
Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux.
Topics: Algorithms; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Beverages; Biological Transport, Active; Caco-2 Cells; Calcium Channel Blockers; Citrus; Cyclosporine; Food-Drug Interactions; HIV Protease Inhibitors; Humans; Immunosuppressive Agents; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Plant Extracts; Propionates; Quinolines; Saquinavir; Transfection; Verapamil; Vinblastine | 2004 |
Morin (3,5,7,2',4'-pentahydroxyflavone) exhibits potent inhibitory actions on urate transport by the human urate anion transporter (hURAT1) expressed in human embryonic kidney cells.
Topics: Benzbromarone; Cell Line; Flavonoids; Humans; Kidney; Organic Anion Transporters; Organic Cation Transport Proteins; Probenecid; Sulfinpyrazone; Transfection; Uric Acid; Uricosuric Agents | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A new class of drugs that inhibit platelet release and aggregation.
Topics: Anions; Biological Transport; Blood Platelets; Exocytosis; Furosemide; Hydrogen-Ion Concentration; Osmolar Concentration; Platelet Aggregation; Probenecid; Pyridoxal Phosphate; Serotonin; Sulfinpyrazone; Suramin; Thrombin | 1978 |
[Physiopathological bases for a rational therapy of gout].
Topics: Allopurinol; Benzofurans; Gout; Humans; Life Style; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid | 1978 |
Committee on the Review of Medicines. Recommendations on phenylbutazone, oxyphenbutazone, feprazone, allopurinol, colchicine, probenecid, and sulphinpyrazone.
Topics: Adult; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Child; Colchicine; Drug Evaluation; Feprazone; Gout Suppressants; Humans; Oxyphenbutazone; Phenylbutazone; Probenecid; Sulfinpyrazone; United Kingdom | 1978 |
Management of gout.
Topics: Adrenal Cortex Hormones; Allopurinol; Colchicine; Female; Gout; Humans; Indomethacin; Patient Education as Topic; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid | 1979 |
Gout.
Topics: Colchicine; Cortisone; Gout; Humans; Male; Probenecid; Sulfinpyrazone | 1979 |
The management of gout.
Topics: Allopurinol; Colchicine; Gout; Humans; Indomethacin; Male; Oxyphenbutazone; Phenylbutazone; Probenecid; Sulfinpyrazone | 1979 |
Management of gout.
Topics: Allopurinol; Colchicine; Gout; Humans; Phenylbutazone; Probenecid; Sulfinpyrazone | 1979 |
Classification of uricosuric states based upon response to pharmacologic inhibitors of urate transport.
Topics: Anemia, Sickle Cell; Aspirin; Biological Transport; Diatrizoate; Fanconi Syndrome; Glomerular Filtration Rate; Humans; Kidney Tubules; Probenecid; RNA; Saline Solution, Hypertonic; Sulfinpyrazone; Uric Acid; Water-Electrolyte Balance | 1977 |
[Drug therapy in uratic arthritis. II. Prevention of new attacks].
Topics: Allopurinol; Gout; Humans; Probenecid; Sulfinpyrazone | 1977 |
Drugs for gout.
Topics: Allopurinol; Colchicine; Gout; Humans; Indomethacin; Oxyphenbutazone; Phenylbutazone; Probenecid; Sulfinpyrazone | 1976 |
The treatment of hyperuricemia.
Topics: Allopurinol; Drug Interactions; Drug Therapy, Combination; Humans; Phenylbutazone; Probenecid; Salicylates; Sulfinpyrazone; Uric Acid; Uricosuric Agents; Xanthine Oxidase | 1976 |
Pharmacokinetic and clinical studies of a new uricosuric agent - benzbromarone.
Topics: Adult; Aged; Arthritis; Benzbromarone; Benzofurans; Chemical Phenomena; Chemistry; Chronic Disease; Gout; Humans; Hydrochlorothiazide; Kinetics; Middle Aged; Probenecid; Sulfinpyrazone; Uric Acid | 1976 |
Current therapy of gout and hyperuricemia.
Topics: Allopurinol; Colchicine; Drug Interactions; Gout; Humans; Indomethacin; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid | 1976 |
Decreasing prevalence of tophaceous gout.
Topics: Colchicine; Gout; Humans; Minnesota; Probenecid; Retrospective Studies; Sulfinpyrazone | 1975 |
[Uricosuric agents: Should they be used in asymptomatic hyperuricemia?].
Topics: Allopurinol; Humans; Metabolic Diseases; Probenecid; Sulfinpyrazone; Uric Acid | 1976 |
[The management of hyperuricemia associated with drug treatment of hypertension].
Topics: Acidosis; Adrenergic beta-Antagonists; Allopurinol; Antihypertensive Agents; Benzothiadiazines; Diuretics; Humans; Probenecid; Sodium Chloride Symporter Inhibitors; Sulfinpyrazone; Uric Acid | 1992 |
Flow cytometric analysis of transport activity in lymphocytes electroporated with a fluorescent organic anion dye.
Topics: Animals; Anions; Antigen-Presenting Cells; Biological Transport, Active; Dinitrophenols; Flow Cytometry; Humans; Isoquinolines; Lymphocytes; Mice; Probenecid; Sulfinpyrazone; T-Lymphocytes, Helper-Inducer; Temperature; Tumor Cells, Cultured | 1992 |
Monoisoamyl meso-2,3-dimercaptosuccinate: interaction with metallothionein-bound cadmium in vitro and evidence of active transport into renal and hepatic cells in vivo.
Topics: Animals; Biological Transport, Active; Cadmium; Kidney; Liver; Male; Metallothionein; Mice; Probenecid; Succinates; Sulfinpyrazone; Thiocarbamates | 1992 |
Organic-anion transport inhibitors to facilitate measurement of cytosolic free Ca2+ with fura-2.
Topics: Animals; Anions; Benzofurans; Biological Transport; Calcium; Cell Line; Cytosol; Fluorescent Dyes; Fura-2; Homeostasis; Macrophages; Probenecid; Sulfinpyrazone | 1989 |
The effects of antibiotics and uricosuric drugs on the renal elimination of methotrexate and 7-hydroxymethotrexate in rabbits.
Topics: Animals; Anti-Bacterial Agents; Benzbromarone; Ceftriaxone; Furosemide; Kidney; Metabolic Clearance Rate; Methotrexate; Piperacillin; Probenecid; Rabbits; Sulfamethoxazole; Sulfinpyrazone; Uricosuric Agents | 1988 |
Hyperuricemia and gout.
Topics: Allopurinol; Anti-Inflammatory Agents; Arthritis; Colchicine; Female; Gout; Humans; Indomethacin; Kidney Calculi; Male; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid | 1985 |
Drugs in the treatment of hyperuricemia.
Topics: Allopurinol; Gout; Humans; Oxypurinol; Probenecid; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1974 |
Zyloprim and other drugs in the management of gout.
Topics: Adrenocorticotropic Hormone; Colchicine; Enzyme Therapy; Enzymes; Gout; Humans; Indomethacin; Probenecid; Sulfinpyrazone; Urinary Calculi; Xanthine Oxidase | 1966 |
[The treatment of gout and the internal medical treatment of uric acid nephrolithiasis].
Topics: Adrenocorticotropic Hormone; Allopurinol; Colchicine; Gout; Humans; Indomethacin; Kidney Calculi; Prednisolone; Probenecid; Sulfinpyrazone; Uricosuric Agents | 1968 |
Recent developments in the therapy of gout.
Topics: Acute Disease; Adrenocorticotropic Hormone; Allopurinol; Analgesics; Colchicine; Gout; Humans; Oxyphenbutazone; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1968 |
[How to treat gout].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anticoagulants; Benzofurans; Colchicine; Gout; Griseofulvin; Humans; Indomethacin; Oxyphenbutazone; Phenylbutazone; Probenecid; Salicylates; Sulfinpyrazone | 1966 |
[Functional nephrography].
Topics: Aminohippuric Acids; Contrast Media; Diuresis; Diuretics; Evaluation Studies as Topic; False Negative Reactions; False Positive Reactions; Humans; Phenylbutazone; Premedication; Probenecid; Radioisotope Renography; Sulfinpyrazone; Thirst; Time Factors | 1972 |
[Cutaneous side effects of systemic drugs with special reference to recently introduced medicaments. I].
Topics: Allopurinol; Analgesics; Chlorothiazide; Colchicine; Drug Eruptions; Humans; Lichen Planus; Photosensitivity Disorders; Probenecid; Quinolines; Stevens-Johnson Syndrome; Sulfinpyrazone | 1970 |
Evidence for a postsecretory reabsorptive site for uric acid in man.
Topics: Absorption; Adult; Aspirin; Female; Humans; Kidney Tubules; Male; Middle Aged; Probenecid; Pyrazinamide; Sulfinpyrazone; Uric Acid | 1973 |
Pyrazinoate excretion in the chimpanzee. Relation to urate disposition and the actions of uricosuric drugs.
Topics: Allopurinol; Aminohippuric Acids; Animals; Biological Transport; Carboxylic Acids; Chlorothiazide; Depression, Chemical; Glomerular Filtration Rate; Insulin; Iodopyracet; Kidney Tubules; Male; Organomercury Compounds; Pan troglodytes; Probenecid; Protein Binding; Pyrazines; Salicylates; Stimulation, Chemical; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1973 |
The binding of urate to plasma proteins.
Topics: Allopurinol; Aspirin; Binding Sites; Blood Proteins; Colchicine; Dialysis; Evaluation Studies as Topic; Gout; Humans; Hydrogen-Ion Concentration; Indomethacin; Kidney Diseases; Kinetics; Methods; Osmolar Concentration; Phenylbutazone; Probenecid; Protein Binding; Serum Albumin; Solubility; Sulfinpyrazone; Temperature; Time Factors; Uric Acid | 1974 |
Evidence for a post-secretory reabsorptive site for uric acid in man.
Topics: Aspirin; Biological Transport; Fasting; Humans; Kidney Tubules; Probenecid; Pyrazinamide; Sulfinpyrazone; Time Factors; Uric Acid | 1974 |
Urate clearance in Cebus monkeys.
Topics: Animals; Chlorothiazide; Cobalt Isotopes; Creatinine; Glomerular Filtration Rate; Haplorhini; Hydroxybutyrates; Inulin; Kidney; Lactates; Probenecid; Sulfinpyrazone; Uric Acid; Vitamin B 12 | 1968 |
Renal effects of uricosuric agents in the Cebus monkey.
Topics: Administration, Oral; Amides; Aminohippuric Acids; Animals; Biotransformation; Chlorothiazide; Glomerular Filtration Rate; Haplorhini; Injections, Intravenous; Inulin; Iodopyracet; Kidney; Phenylbutazone; Probenecid; Species Specificity; Sulfinpyrazone; Uric Acid; Uricosuric Agents; Zoxazolamine | 1970 |
Medical management of gout.
Topics: Adult; Allopurinol; Colchicine; Diet Therapy; Female; Gout; Humans; Kidney Diseases; Male; Middle Aged; Oxyphenbutazone; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid | 1972 |
[Pharmacological studies of diuretics. 4. Changes of serum uric acid level by the succesive administration of thiazide diuretics and other drugs and effects of uricosuric drugs].
Topics: Administration, Oral; Allopurinol; Ammonium Chloride; Animals; Barbiturates; Blood Glucose; Chlorothiazide; Cyclohexanes; Diuretics; Electrolytes; Ethacrynic Acid; Glycine; Hydrochlorothiazide; Hydroflumethiazide; Injections, Subcutaneous; Male; Nucleosides; Phenylbutazone; Probenecid; Quinolines; Rats; Sulfinpyrazone; Sulfonamides; Thiadiazines; Uric Acid; Uricosuric Agents; Xanthenes | 1971 |
[Effect of transtubular transport inhibitors in the renal excretion of uric acid in the rat].
Topics: Aminohippuric Acids; Animals; Hydrochlorothiazide; Kidney; Kidney Tubules; Male; Metabolic Clearance Rate; Probenecid; Rats; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1971 |
[Gout from the view of a special hospital for rheumatic patients].
Topics: Acute Disease; Adolescent; Adult; Aged; Austria; Child; Cholesterol; Colchicine; Colic; Diabetes Complications; Diagnosis, Differential; Diagnostic Errors; Gout; Heart Diseases; Hospitals, Special; Humans; Indomethacin; Kidney Diseases; Middle Aged; Obesity; Phenylbutazone; Probenecid; Prognosis; Radiography; Rheumatic Diseases; Sulfinpyrazone; Time Factors; Uric Acid; Uricosuric Agents | 1971 |
[Renal excretion of uric acid in rats].
Topics: Animals; Glomerular Filtration Rate; Hydrochlorothiazide; Kidney Concentrating Ability; Probenecid; Rats; Sulfinpyrazone; Uric Acid | 1969 |
[Gout in dermatology].
Topics: Adolescent; Aged; Colchicine; Diagnosis, Differential; Gout; Humans; Indomethacin; Joint Diseases; Male; Middle Aged; Osteoporosis; Phenylbutazone; Probenecid; Radiography; Skin Diseases; Skin Ulcer; Sulfinpyrazone; Toes | 1969 |
Effect of drugs on the binding of urate to human albumin.
Topics: Allopurinol; Aspirin; Colchicine; Humans; Indomethacin; Phenylbutazone; Probenecid; Protein Binding; Serum Albumin; Sulfinpyrazone; Uric Acid | 1970 |
Effect of some uricosuric and anti-inflammatory drugs on the binding of uric acid to human serum albumin in vitro.
Topics: Allopurinol; Anti-Inflammatory Agents; Aspirin; Binding Sites; Caprylates; Colchicine; Dialysis; Fluorescence; Humans; In Vitro Techniques; Indomethacin; Mefenamic Acid; Phenylbutazone; Probenecid; Protein Binding; Serum Albumin; Sodium Salicylate; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1970 |
Pathogenesis and medical management of chronic gouty arthritis.
Topics: Allopurinol; Chronic Disease; Colchicine; Gout; Humans; Joints; Kidney; Probenecid; Sulfinpyrazone; Uric Acid | 1970 |
Renal effects of uricosuric agents in the chimpanzee.
Topics: Aminohippuric Acids; Animals; Benzoates; Benzyl Compounds; Chlorothiazide; Electrolytes; Glomerular Filtration Rate; Hominidae; Hydrochlorothiazide; Inulin; Iodopyracet; Kidney; Male; Probenecid; Sodium Salicylate; Sulfinpyrazone; Sulfonamides; Uric Acid; Uricosuric Agents; Zoxazolamine | 1971 |
[Therapy of arthritis urica].
Topics: Analgesics; Diet Therapy; Gout; Humans; Probenecid; Sulfinpyrazone | 1968 |
Etiology and treatment of gout--modern concepts.
Topics: Allopurinol; Colchicine; Crystallization; Diagnosis, Differential; Diet Therapy; Gout; Humans; Indomethacin; Joint Diseases; Kidney Diseases; Kidneys, Artificial; Phenylbutazone; Probenecid; Proteinuria; Purines; Radiography; Salicylates; Steroids; Sulfinpyrazone; Uric Acid | 1968 |
A short trial assessment of uricosuric therapy in gout.
Topics: Adult; Aged; Allopurinol; Female; Glomerular Filtration Rate; Gout; Humans; Male; Middle Aged; Probenecid; Sulfinpyrazone; Uric Acid | 1968 |
[Gout in advanced age].
Topics: Age Factors; Aged; Allopurinol; Bone and Bones; Cardiovascular Diseases; Colchicine; Female; Gout; Humans; Hyperlipidemias; Hypertension; Kidney Diseases; Male; Probenecid; Sodium; Sulfinpyrazone; Uric Acid | 1968 |
Goals in gout.
Topics: Allopurinol; Colchicine; Gout; Humans; Probenecid; Sulfinpyrazone | 1969 |
Allopurinol (xanthine oxidase inhibitor) in the treatment of resistant gout.
Topics: Adult; Aged; Colchicine; Enzyme Therapy; Enzymes; Female; Gout; Humans; Male; Middle Aged; Probenecid; Sulfinpyrazone; Uric Acid; Xanthine Oxidase | 1966 |
Kinetics of uric acid transport and its production in rat small intestine.
Topics: Animals; Biological Transport, Active; Carbon Isotopes; Chromatography, Paper; Female; Hypoxanthines; Intestine, Small; Kinetics; Probenecid; Rats; Spectrophotometry; Sulfinpyrazone; Uric Acid | 1967 |
Therapy of gout.
Topics: Allopurinol; Colchicine; Gout; Humans; Phenylbutazone; Probenecid; Sulfinpyrazone | 1967 |
Potentiation of morphine analgesia after pretreatment with probenecid or sulfinpyrazone.
Topics: Analgesia; Animals; Benzoquinones; Dose-Response Relationship, Drug; Drug Synergism; Male; Morphine; Probenecid; Quinones; Rats; Rats, Inbred Strains; Sulfinpyrazone | 1983 |
Potentiation of barbiturate- and halothane-induced hypnosis after probenecid or sulfinpyrazone pretreatment.
Topics: Animals; Dose-Response Relationship, Drug; Drug Synergism; Female; Halothane; Hypnosis; Pentobarbital; Premedication; Probenecid; Rats; Rats, Inbred Strains; Reaction Time; Sulfinpyrazone | 1982 |
[Effect of long-term base therapy on the clinical picture of gout].
Topics: Adult; Allopurinol; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Female; Gout; Humans; Male; Middle Aged; Probenecid; Sulfinpyrazone; Time Factors; Uric Acid | 1981 |
Practical therapeutics treatment of gout.
Topics: Colchicine; Female; Gout; Humans; Indomethacin; Male; Phenylbutazone; Probenecid; Sulfinpyrazone | 1981 |
[Changes in indications for drugs].
Topics: Amantadine; Clofibrate; Colchicine; Drug Therapy; Female; Gout; Humans; Levamisole; Metronidazole; Middle Aged; Probenecid; Sulfinpyrazone | 1980 |
Probenecid-resistant J774 cell expression of enhanced organic anion transport by a mechanism distinct from multidrug resistance.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cell Line; Colchicine; Drug Resistance; Ion Transport; Isoquinolines; Macrophages; Membrane Glycoproteins; Mice; Probenecid; Sulfinpyrazone | 1993 |
Suppression of cAMP-induced pigment granule aggregation in RPE by organic anion transport inhibitors.
Topics: Animals; Anions; Biological Transport; Cell Aggregation; Cells, Cultured; Cyclic AMP; Cytoplasmic Granules; Dark Adaptation; Melanophores; Perciformes; Pigment Epithelium of Eye; Probenecid; Sulfinpyrazone | 1994 |
Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles.
Topics: Aged; Benzbromarone; Biological Transport; Biphenyl Compounds; Carbon Radioisotopes; Diuretics; Ethambutol; Humans; Imidazoles; Kidney Cortex; Kidney Neoplasms; Kinetics; Losartan; Microvilli; Middle Aged; Probenecid; Pyrazinamide; Salicylates; Salicylic Acid; Sulfinpyrazone; Tetrazoles; Ticrynafen; Uric Acid; Uricosuric Agents | 1997 |
Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Astrocytes; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzbromarone; Brain; Capillaries; Carcinogens; Cell Line, Transformed; Colchicine; Cyclosporine; DNA-Binding Proteins; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Genistein; Gout Suppressants; Immunoblotting; Multidrug Resistance-Associated Proteins; MutS Homolog 3 Protein; Polymerase Chain Reaction; Probenecid; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sulfinpyrazone; Uricosuric Agents; Vinblastine; Vincristine | 1998 |
Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export.
Topics: Anion Transport Proteins; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Benzbromarone; Biological Transport, Active; Carrier Proteins; Dose-Response Relationship, Drug; Glutathione; Humans; Indomethacin; Probenecid; Sulfinpyrazone; Tumor Cells, Cultured; Uricosuric Agents; Vinblastine | 2000 |
TREATMENT OF THE PATIENT WITH GOUT.
Topics: Chlorthalidone; Colchicine; Diagnosis; Gout; Humans; Oxyphenbutazone; Phenylbutazone; Probenecid; Pyrazoles; Salicylates; Sulfinpyrazone; Uricosuric Agents | 1963 |
THE EFFECT OF SULFINPYRAZONE ("ANTURAN") ON THE PLASMA LEVELS OF PENICILLIN.
Topics: Blood; Humans; Penicillins; Plasma; Probenecid; Sulfinpyrazone; Uricosuric Agents | 1964 |
[THE TREATMENT OF CHRONIC INFLAMMATORY RHEUMATISM IN ADULTS].
Topics: Adrenal Cortex Hormones; Antimalarials; Arthritis; Arthritis, Rheumatoid; Aspirin; Colchicine; Collagen Diseases; Cortisone; Exercise Therapy; Gold; Gout; Humans; Mineral Waters; Phenylbutazone; Probenecid; Rheumatic Fever; Spondylitis; Spondylitis, Ankylosing; Sulfinpyrazone; Uricosuric Agents; Zoxazolamine | 1964 |
THE MODERN MANAGEMENT OF GOUT.
Topics: Adrenocorticotropic Hormone; Blood; Body Fluids; Colchicine; Diet; Diet Therapy; Disease Management; Drug Therapy; Gout; Indoles; Phenylbutazone; Probenecid; Salicylates; Sulfinpyrazone; Surgical Procedures, Operative; Toxicology; Uricosuric Agents; Urine | 1964 |
EXHIBIT ON GOUT.
Topics: Colchicine; Exhibitions as Topic; Gout; Humans; Metabolism; Probenecid; Purines; Sulfinpyrazone; Uricosuric Agents | 1964 |
THE TREATMENT OF GOUT.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Colchicine; Diet; Diet Therapy; Drug Therapy; Geriatrics; Gout; Kidney Diseases; Metabolism; Phenylbutazone; Probenecid; Salicylates; Sulfinpyrazone; Surgical Procedures, Operative; Toxicology; Uric Acid; Uricosuric Agents; Zoxazolamine | 1964 |
GOUT.
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Colchicine; Diagnosis, Differential; Diet; Diet Therapy; Drug Therapy; Epidemiology; Genetics, Medical; Gout; Humans; Indomethacin; Kidney Diseases; Kidneys, Artificial; Phenylbutazone; Probenecid; Salicylates; Sulfinpyrazone; Uric Acid; Urine | 1964 |
EFFECT OF SULFINPYRAZONE ON SERUM URIC ACID IN GOUT. A LONG-TERM STUDY.
Topics: Adolescent; Aging; Blood; Drug Therapy; Geriatrics; Gout; Longitudinal Studies; Metabolism; Phenylbutazone; Probenecid; Salicylates; Sex; Sulfinpyrazone; Toxicology; Uric Acid | 1964 |
FACTORS INFLUENCING RENAL EXCRETION OF FOREIGN ORGANIC ACIDS.
Topics: Acetates; Anilides; Animals; Benzoates; Benzothiadiazines; Bicarbonates; Dinitrophenols; Dogs; Fluids and Secretions; Gentisates; Hydrogen-Ion Concentration; Kidney; Kidney Tubules; Metabolism; Nitrobenzenes; p-Aminohippuric Acid; Phenylbutazone; Probenecid; Quinolines; Renal Elimination; Research; Salicylic Acid; Succinates; Sulfinpyrazone; Uricosuric Agents; Urine | 1964 |
THE PROGRESSIVE NATURE OF GOUT WITH INADEQUATE THERAPY.
Topics: Diagnosis; Drug Therapy; Gout; Humans; Pathology; Probenecid; Radiography; Sulfinpyrazone | 1965 |
INHIBITORS OF PENICILLIN BINDING TO SERUM PROTEINS.
Topics: Acetazolamide; Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antimetabolites; Aspirin; Benzoates; Biguanides; Blood Proteins; Carbon Isotopes; Chlorothiazide; Diuretics; Ethacrynic Acid; Guanidines; Oxazoles; p-Aminohippuric Acid; Penicillin G; Penicillin V; Penicillins; Pharmacology; Phenylbutazone; Probenecid; Rabbits; Research; Salicylates; Sulfinpyrazone; Sulfonamides; Tolbutamide | 1965 |
THE RENAL EXCRETION OF OXYPURINES.
Topics: Enzyme Inhibitors; Fluids and Secretions; Gout; Hypoxanthines; Kidney; Pharmacology; Physiology; Probenecid; Purines; Pyrimidines; Renal Elimination; Salicylates; Spectrophotometry; Sulfinpyrazone; Uricosuric Agents; Urine; Xanthine Oxidase; Xanthines | 1965 |
[GOUT, DIAGNOSIS AND TREATMENT].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Colchicine; Diagnosis; Drug Therapy; Gout; Humans; Leukocyte Count; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid | 1965 |
URATE DIURETIC THERAPY IN CHRONIC GOUT; A COMPARATIVE STUDY OF PROBENECID AND SULFINPYRAZONE.
Topics: Arthritis, Gouty; Biomedical Research; Blood; Diuretics; Drug Therapy; Gout; Humans; Kidney Calculi; Kidney Function Tests; Probenecid; Sulfinpyrazone; Toxicology; Uric Acid; Urinary Calculi | 1965 |
ACUTE ANAPHYLACTOID REACTION TO PROBENECID.
Topics: Anaphylaxis; Colchicine; Diagnosis, Differential; Drug Therapy; Gout; Myocardial Infarction; Probenecid; Sulfinpyrazone; Toxicology | 1965 |
Benemid, flexin and anturane as uricosuric agents.
Topics: Humans; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid; Uricosuric Agents; Zoxazolamine | 1962 |
UV or X-irradiation increases the cytoplasmic accumulation of rhodamine 123 in various cancer cell lines.
Topics: Apoptosis; ATP-Binding Cassette Transporters; Cell Death; Cell Line; Cyclosporine; Cytoplasm; Flow Cytometry; Humans; Lymphocytes; Phenotype; Probenecid; Radiation Dosage; Radiation, Ionizing; Rhodamines; Sulfinpyrazone; Tumor Cells, Cultured; Ultraviolet Rays; Verapamil; X-Rays | 2003 |
Potential roles of P-gp and calcium channels in loperamide and diphenoxylate transport.
Topics: Antidiarrheals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caco-2 Cells; Calcium Channel Blockers; Calcium Channels; Cyclosporine; Cyclosporins; Diphenoxylate; Drug Interactions; Humans; Loperamide; Narcotics; Probenecid; Sulfinpyrazone; Verapamil | 2003 |
Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter.
Topics: Animals; Binding, Competitive; Blotting, Western; Carrier Proteins; Cell Line; Computer Systems; Dogs; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Insecta; Kidney; Membrane Transport Modulators; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Osmolar Concentration; p-Aminohippuric Acid; Polymerase Chain Reaction; Probenecid; Rats; Rats, Mutant Strains; Rats, Wistar; RNA, Messenger; Sulfinpyrazone | 2004 |
Block of CFTR-dependent chloride currents by inhibitors of multidrug resistance-associated proteins.
Topics: Animals; ATP-Binding Cassette Transporters; Benzbromarone; Cells, Cultured; Chloride Channels; Cystic Fibrosis Transmembrane Conductance Regulator; Probenecid; Rats; Rats, Inbred F344; Sulfinpyrazone | 2007 |
Molecular epidemiology of malaria in Cameroon. XXVI. Twelve-year in vitro and molecular surveillance of pyrimethamine resistance and experimental studies to modulate pyrimethamine resistance.
Topics: Adolescent; Animals; Antimalarials; Cameroon; DNA, Protozoan; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Molecular Epidemiology; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Probenecid; Pyrimethamine; Sequence Analysis, DNA; Sulfinpyrazone; Tetrahydrofolate Dehydrogenase | 2007 |
Uric acid lowering therapy: prescribing patterns in a large cohort of older adults.
Topics: Age Factors; Aged; Aged, 80 and over; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Black or African American; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Gout; Gout Suppressants; Humans; Logistic Models; Male; Massachusetts; Patient Compliance; Probenecid; Sulfinpyrazone; White People | 2008 |
Adherence with urate-lowering therapies for the treatment of gout.
Topics: Age Factors; Allopurinol; Female; Gout; Gout Suppressants; Humans; Male; Medication Adherence; Middle Aged; Probenecid; Sulfinpyrazone; Uric Acid | 2009 |
Interactions of urate transporter URAT1 in human kidney with uricosuric drugs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzbromarone; Benzothiazoles; Biological Transport; Captopril; Cells, Cultured; Dogs; Enalapril; Indomethacin; Inhibitory Concentration 50; Organic Anion Transporters; Organic Cation Transport Proteins; Phenylbutazone; Probenecid; Pyridines; Salicylates; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 2011 |
TRPA1 agonist activity of probenecid desensitizes channel responses: consequences for screening.
Topics: Animals; Calcium Channels; CHO Cells; Coloring Agents; Cricetinae; Cricetulus; Drug Evaluation, Preclinical; HEK293 Cells; Humans; Indicator Dilution Techniques; Ion Channels; Nerve Tissue Proteins; Patch-Clamp Techniques; Probenecid; Renal Agents; Sulfinpyrazone; Transient Receptor Potential Channels; TRPA1 Cation Channel | 2012 |
Phenobarbital induction and chemical synergism demonstrate the role of UDP-glucuronosyltransferases in detoxification of naphthalophos by Haemonchus contortus larvae.
Topics: Animals; Anthelmintics; Drug Resistance; Drug Synergism; Enzyme Induction; Enzyme Inhibitors; Gene Expression Regulation; Glucuronosyltransferase; Haemonchus; Helminth Proteins; Inactivation, Metabolic; Larva; Organophosphorus Compounds; Phenobarbital; Probenecid; Sulfinpyrazone; Uracil | 2014 |
The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012.
Topics: Aged; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; British Columbia; Colchicine; Comorbidity; Diabetes Mellitus; Febuxostat; Female; Glucocorticoids; Gout; Gout Suppressants; Humans; Hyperlipidemias; Hypertension; Incidence; Male; Middle Aged; Population Growth; Prevalence; Probenecid; Sulfinpyrazone; Uricosuric Agents | 2017 |
Intestinal UDP-glucuronosyltransferase as a potential target for the treatment and prevention of lymphatic filariasis.
Topics: Albendazole; Animals; Antigens, Helminth; Brugia malayi; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Glucuronosyltransferase; Humans; Immunoglobulin E; Intestines; Microfilariae; Movement; Probenecid; RNA, Small Interfering; Sulfinpyrazone | 2019 |